Results 151 to 160 of about 89,290 (238)

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial.

Lancet. Infectious Diseases (Print), 2017
A. Torres, N. Zhong, J. Pachl, J. Timsit, M. Kollef, Zhangjing Chen, Jie Song, D. Taylor, P. Laud, G. Stone, J. Chow   +10 more
semanticscholar   +1 more source

Evidence of intrapulmonary penetration of nacubactam, a novel β-lactamase inhibitor, following coadministration of nacubactam with meropenem in healthy adults. [PDF]

Antimicrob Agents Chemother
Morita J, Ishiwata K, Matsumoto S, Kato S, Attley G, Patel K, Rodriguez I, Mallalieu NL.   +7 more
europepmc   +1 more source

Extended vs Intermittent Infusion of Meropenem with Colistimethate Sodium and Risk of Acute Kidney Injury in Critically Ill Patients: A Propensity Score-Matched Retrospective Cohort Study. [PDF]

Infect Drug Resist
Hu Q, Wang H.
europepmc   +1 more source

Meropenem stress drives lipid remodeling and resistance gene dissemination via outer membrane vesicles in carbapenem-resistant <i>Klebsiella pneumoniae</i>. [PDF]

Curr Res Microb Sci
Fan F, Shi Q, Chen G, Zhan H, Deng S, Peng Y, Wei L.   +6 more
europepmc   +1 more source

Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients. [PDF]

J Antimicrob Chemother
Cojutti PG, Toschi A, Pasquini Z, Paolini S, Maffini E, Bonifazi F, Zinzani PL, Giannella M, Viale P, Pea F.   +9 more
europepmc   +1 more source

Nacubactam: a review on mechanistic insights and therapeutic promise for combating β-lactam resistance among multidrug-resistant Gram-negative pathogens. [PDF]

Ann Med Surg (Lond)
Kumar D, Kaur N, Surender, Aman S, Bibi A.   +4 more
europepmc   +1 more source

Treatment of Post-Neurosurgical Ventriculitis and Scalp Infection Caused by Klebsiella pneumoniae Carbapenemase and New Delhi Metallo-β-Lactamase Co-Producing Carbapenem-Resistant Klebsiella pneumoniae: A Case Report. [PDF]

Cureus
Ma XR, Chen SY, Wu RH, Li Q, Zhang JM, Ni M, Shen F.   +6 more
europepmc   +1 more source

Antimicrobial susceptibility trends of WHO critical Gram-negative pathogens in Fijian Hospitals, 2016-2021. [PDF]

JAC Antimicrob Resist
Baleivanualala SC, Soqo V, Smita S, Sharma S, Devi SV, Delaitoga L, Maharaj K, Autar S, Racolo T, Vera N, Naivalu TK, Wilson D, Crump JA, Ussher JE.   +13 more
europepmc   +1 more source

Antibiotic Stewardship: Comparing Meropenem De-Escalation and Continued Therapy When Cultures Show No Multi-Drug Resistance. [PDF]

Cureus
Swieczkowski S, Hernandez IA, Brathwaite EE, McCue VY, Castillo M, Saxena A.   +5 more
europepmc   +1 more source

Simultaneous measurement of piperacillin, tazobactam and meropenem in patient samples using LC-MS/MS to support β-lactam therapeutic drug monitoring.

Anal Methods
Federico S, Williams S, Wilson RC, Arkel P, Gilchrist MJ, Holmes AH, Rawson TM, Riezk A.   +7 more
europepmc   +1 more source